Innova Captab Limited (INNOVACAP) - Net Assets

Latest as of March 2026: Rs10.91 Billion INR ≈ $117.97 Million USD

Based on the latest financial reports, Innova Captab Limited (INNOVACAP) has net assets worth Rs10.91 Billion INR (≈ $117.97 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs18.37 Billion ≈ $198.71 Million USD) and total liabilities (Rs7.47 Billion ≈ $80.74 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check INNOVACAP goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs10.91 Billion
% of Total Assets	59.37%
Annual Growth Rate	42.93%
5-Year Change	422.9%
10-Year Change	N/A
Growth Volatility	375.73

Innova Captab Limited - Net Assets Trend (2018–2026)

This chart illustrates how Innova Captab Limited's net assets have evolved over time, based on quarterly financial data. See INNOVACAP defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Innova Captab Limited (2018–2026)

The table below shows the annual net assets of Innova Captab Limited from 2018 to 2026. For live valuation and market cap data, see INNOVACAP company net worth.

Year	Net Assets	Change
2026-03-31	Rs10.91 Billion ≈ $117.97 Million	+13.69%
2025-03-31	Rs9.59 Billion ≈ $103.76 Million	+15.47%
2024-03-31	Rs8.31 Billion ≈ $89.86 Million	+155.20%
2023-03-31	Rs3.26 Billion ≈ $35.21 Million	+56.08%
2022-03-31	Rs2.09 Billion ≈ $22.56 Million	+44.04%
2021-03-31	Rs1.45 Billion ≈ $15.66 Million	-61.86%
2020-03-31	Rs3.80 Billion ≈ $41.06 Million	+1144.45%
2019-03-31	Rs305.11 Million ≈ $3.30 Million	-51.27%
2018-03-31	Rs626.18 Million ≈ $6.77 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Innova Captab Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (March 2026)

Component	Amount	Percentage
Common Stock	Rs572.25 Million	5.25%
Other Components	Rs10.34 Billion	94.75%
Total Equity	Rs10.91 Billion	100.00%

Innova Captab Limited Competitors by Market Cap

The table below lists competitors of Innova Captab Limited ranked by their market capitalization.

Company	Market Cap
Cheng Uei Precision Industry Co Ltd TW:2392	$586.91 Million
Actron Technology TWO:8255	$586.91 Million
Ares Acquisition Corporation II NYSE:AACT	$587.05 Million
Ningbo Fangzheng Automobile Mould Co.Ltd. SHE:300998	$587.11 Million
Red River Bancshares Inc NASDAQ:RRBI	$586.56 Million
Tian Jin Global Magnetic Card Co Ltd SHG:600800	$586.39 Million
Core Laboratories NV NYSE:CLB	$586.35 Million
Beijing Jingpin Tezhuang Technology Co. Ltd. A SHG:688084	$586.34 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Innova Captab Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2025 to 2026, total equity changed from 9,594,170,000 to 10,907,920,000, a change of 1,313,750,000 (13.7%).
Net income of 1,409,170,000 contributed positively to equity growth.
Dividend payments of 114,430,000 reduced retained earnings.
Other comprehensive income decreased equity by 712,390,000.
Other factors increased equity by 731,400,000.

Equity Change Factors (2025 to 2026)

Factor	Impact	Contribution
Net Income	Rs1.41 Billion	+12.92%
Dividends Paid	Rs114.43 Million	-1.05%
Other Comprehensive Income	Rs-712.39 Million	-6.53%
Other Changes	Rs731.40 Million	+6.71%
Total Change	Rs-	13.69%

Book Value vs Market Value Analysis

This analysis compares Innova Captab Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 4.97x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 72.67x to 4.97x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2018-03-31	Rs13.05	Rs947.95	x
2019-03-31	Rs5.33	Rs947.95	x
2020-03-31	Rs15.89	Rs947.95	x
2021-03-31	Rs25.31	Rs947.95	x
2022-03-31	Rs36.45	Rs947.95	x
2023-03-31	Rs48.32	Rs947.95	x
2024-03-31	Rs164.33	Rs947.95	x
2025-03-31	Rs167.64	Rs947.95	x
2026-03-31	Rs190.65	Rs947.95	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Innova Captab Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 12.92%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 8.65%
• Asset Turnover: 0.89x
• Equity Multiplier: 1.68x
Recent ROE (12.92%) is below the historical average (31.88%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2018	19.06%	5.05%	1.17x	3.23x	Rs56.75 Million
2019	114.61%	7.08%	1.50x	10.77x	Rs319.18 Million
2020	36.57%	7.47%	0.98x	4.98x	Rs202.60 Million
2021	23.82%	8.42%	1.11x	2.55x	Rs200.18 Million
2022	30.66%	8.00%	1.39x	2.76x	Rs430.92 Million
2023	24.58%	7.34%	0.91x	3.68x	Rs403.03 Million
2024	11.35%	8.76%	0.82x	1.59x	Rs112.56 Million
2025	13.37%	10.31%	0.79x	1.65x	Rs323.16 Million
2026	12.92%	8.65%	0.89x	1.68x	Rs318.38 Million

Industry Comparison

This section compares Innova Captab Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $15,442,194,716
Average return on equity (ROE) among peers: 17.47%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Innova Captab Limited (INNOVACAP)	Rs10.91 Billion	19.06%	0.68x	$586.65 Million
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)	$865.53 Million	7.56%	0.68x	$24.33 Million
Aarti Drugs Limited (AARTIDRUGS)	$10.36 Billion	19.79%	1.13x	$370.54 Million
Aarti Pharmalabs Limited (AARTIPHARM)	$15.58 Billion	12.42%	0.44x	$628.04 Million
Abbott India Limited (ABBOTINDIA)	$2.46 Billion	24.35%	0.39x	$6.03 Billion
Ajanta Pharma Limited (AJANTPHARM)	$29.96 Billion	21.83%	0.26x	$4.13 Billion
Akums Drugs and Pharmaceutical (AKUMS)	$30.64 Billion	11.04%	0.34x	$1.03 Billion
Alkem Laboratories Limited (ALKEM)	$30.85 Billion	12.69%	0.72x	$6.90 Billion
Amrutanjan Health Care Limited (AMRUTANJAN)	$234.13 Million	25.26%	0.77x	$173.35 Million
Alembic Pharmaceuticals Limited (APLLTD)	$22.20 Billion	18.58%	0.77x	$1.57 Billion
Aurobindo Pharma Limited (AUROPHARMA)	$11.27 Billion	21.16%	2.22x	$8.76 Billion

About Innova Captab Limited

NSE:INNOVACAP India Drug Manufacturers - Specialty & Generic

Market Cap

$586.65 Million

Rs54.25 Billion INR

Market Cap Rank

#11621 Global

#561 in India

Share Price

Rs947.95

Change (1 day)

+0.58%

52-Week Range

Rs644.75 - Rs950.75

All Time High

Rs1240.00